2024 Packaging Pharmaceutical Companies 
European Pharmaceutical Review
NOVEMBER 1, 2024
The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion by 2033, according to a study published by Towards Packaging. percent between 2024 and 2033. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.
European Pharmaceutical Review
APRIL 26, 2024
“approval [of Pyzchiva ® (biosimilar ustekinumab)] of is a crucial step towards offering European patients an additional safe and effective treatment option” Pharmaceutical company Sandoz has announced that the European Commission (EC) has granted marketing authorisation for Pyzchiva ® (biosimilar ustekinumab ).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 12, 2021
With an attractive corporate tax rate and the youngest workforce in the EU, Ireland continues to be a popular destination for life science companies to settle. Although cities such as Dublin and Cork were the traditional centres for pharmaceutical companies, a new wave of regional investment is happening across the country.
pharmaphorum
MARCH 10, 2022
Accordingly, pharmaceutical companies are expected to up their investment in this area, both in terms of production infrastructure and expertise.”. “This trend will continue in the near future with a steady increase in market demand over the coming years, alongside further development in cell and gene therapies,” says Magnelli.
Pharmaceutical Technology
MAY 23, 2023
The recent legislative reform proposals put forward by the European Commission (EC) have sparked significant discontent among pharmaceutical companies. While a handful of incentives are offered by the reform package, they are overshadowed by the potential drawbacks for the innovative sector.
Roots Analysis
AUGUST 1, 2024
GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. per package in the US. Examples of some partnerships in this domain include: In May 2024, Sciwind Biosciences and HK inno.N
The Checkup by Singlecare
MARCH 10, 2025
Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. The list price of brand-name forms of semaglutide ranges from $998$1,349 per package, typically a months supply, depending on the dosage prescribed. For those licensed by the FDA, the deadline is May 22, 2025.
Expert insights. Personalized for you.
52 
Let's personalize your content